Neurocrine Biosciences
NBIXNeurocrine Biosciences is a publicly traded biopharmaceutical company founded in 1992. The company is headquartered in San Diego, California, and led by CEO Kevin Gorman. Neurocrine develops treatments for neurological and endocrine-related diseases and disorders. In 2017, the company's drug valbena …
© Wikipedia /
Creative Commons CC-BY-SA 3.0 more at Wikipedia
Insider trades and stock quote 2024-2026
All insider trades at Neurocrine Biosciences
Subscribe RSS| Date | Type | Insider | Position | Ø-Price | Volume |
|---|---|---|---|---|---|
| 7/10/2026 | Sell | Delaet, Ingrid | Chief Regulatory Officer | $181.0 | $790,514 |
| 7/9/2026 | Sell | Lippoldt, Darin | Chief Legal Officer | $179.6 | $1,796,014 |
| 7/9/2026 | Sell | Delaet, Ingrid | Chief Regulatory Officer | $178.7 | $1,507,135 |
| 7/8/2026 | Sell | Delaet, Ingrid | Chief Regulatory Officer | $178.5 | $488,672 |
| 7/7/2026 | Sell | Delaet, Ingrid | Chief Regulatory Officer | $178.6 | $607,305 |
All information without guarantee! No recommendation/consultation!
© U.S. Securities and Exchange Commission (SEC)